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Purpose: The true benefit of autologous platelet concentrates (APCs) for enhancing the healing of
postextraction sites is still a matter of debate, and in recent years several clinical trials have addressed
this issue. The purpose of this study was to determine the effectiveness of an APC adjunct in the preser-
vation of fresh extraction sockets.
Materials and Methods: An electronic search was performed on Medline, Embase, Scopus, and the
Cochrane Central Register of Controlled Trials. Only controlled clinical trials or randomized clinical trials
were included. Selected articles underwent risk-of-bias assessment. The outcomeswere complications and
adverse events, discomfort and quality of life, bone healing and remodeling assessed by histologic and
radiographic techniques, and soft tissue healing.
Results: Thirty-three comparative studies were included. Nine articles had a parallel design and 24 had a
split-mouth design. Twenty studies were considered to have a low risk of bias and 13 were considered to
have a high risk. Overall, 1,193 teeth were extracted from 911 patients. Meta-analysis showed that soft tis-
sue healing, probing depth at 3 months, and bone density at 1, 3, and 6 month were statistically better for
the APC group. Qualitative analysis suggested that APCs might be associated with a decrease in swelling
and trismus. However, no relevant difference among groups was found for probing depth at 1 month, inci-
dence of alveolar osteitis, acute inflammation or infection, percentage of new bone, and indirect measure-
ment of bone metabolism.
Conclusion: APCs should be used in postextraction sites to improve clinical and radiographic outcomes
such as bone density and soft tissue healing and postoperative symptoms. The actual benefit of APCs on
decreasing on pain in extraction sockets is still not quantifiable.
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Tooth extraction is one of the most frequent proced-
ures in oral and maxillofacial surgery and is related
to consistent physiologic changes to the alveolar pro-
cess. The main extraction-related postoperative symp-
toms affecting soft tissues and patient quality of life are
pain, bleeding, trismus, and swelling. Other postoper-
ative complications are delayed healing and infection.1
Hard tissues also are affected: tooth extraction always
triggers a process of bone resorption. The alveolar
ridge undergoes progressive atrophy, which is more
severe in the buccolingual dimension than in the
apico-coronal dimension.2 Most of the resorption pro-
cess occurs during the first 6months of the postextrac-
tion period, although it continues throughout the
patient’s lifetime.3
Bone loss and changes in the soft tissue profile re-
sulting from tooth loss4 and an unpleasant esthetic
aspect can hinder rehabilitation of the edentulous
ridge using removable or fixed prostheses. Previous
studies have found that postextraction sockets that
do not undergo preservation treatment frequently
require additional bone augmentation at the time of
implant placement compared with postextraction
sockets treated with preservation techniques.2 Many
different socket preservation techniques have been
proposed over the years, most of them consisting of
the placement of a graft material (bone or bone substi-
tutes) into the socket with or without the positioning
of a covering membrane.5-10 A recent systematic
review reported that resorption of the alveolar ridge
cannot be totally avoided, although it can be
prevented with the use of alveolar ridge preservation
techniques, but that no specific technique proved to
be superior to another.11,12
Among the available options for decreasing postop-
erative symptoms and preserving postextraction
sockets are autologous platelet concentrates (APCs).
The most popular of such heme components are
platelet-rich plasma (PRP), plasma rich in growth fac-
tors (PRGF), and platelet-rich fibrin (PRF). A common
feature of all these APCs is the higher than baseline
concentration of platelets, which has been shown to
play an important role in tissue healing. Their effec-
tiveness lies in the continuous and local release of a
FIGURE 1. Flowchart of article selection procedure. Q4
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wide range of growth factors, whichmeet the needs of
the physiologic process of wound healing and tissue
repair. Growth factors are biological mediators
capable of regulating cellular events, such as migra-
tion, cell proliferation, and differentiation in addition
to synthesis of the extracellular matrix.13,14
The application of APCs for wound healing of post-
extraction sites has been investigated in several clin-
ical trials. A previous evidence-based systematic
review on this topic, based on strict inclusion criteria,
concluded that the beneficial effects of APCs were
generally but not systematically reported in most









FU (wk)Test Control Test Control
Alissa et al, 201017 RCT (pa) 23 30.5 (20-52) 15 14 PRP None 12
Ogundipe et al, 201118 RCT (pa) 60 24.7 (19-35) 30 30 PRP None 16
Girish Rao et al, 201320 RCT (sm) 22 NR 22 22 PRF None 24
Kumar et al, 201623 RCT (sm) 42 NR (18-40) 42 42 PRF None 24
Ozgul et al, 201524 RCT (sm) 56 NR (18-28) 56 56 PRF None 1
Anitua et al, 201525 RCT (pa) 60 NR (18-74) 36 24 PRGF None 10-12
Baslarli et al, 201526 RCT (sm) 20 23.9 (19-34) 20 20 PRF None 4-12
Dutta et al, 201527 RCT (pa) 60 33.8 PRP, 35.3
control (18-50)
30 30 PRP None 24
Kumar et al, 201528 RCT (pa) 31 26.1 (19-35) 16 15 PRF None 12
Marenzi et al, 201529 RCT (sm) 26 53 (NR) PRF None 3
Uyanık et al, 201530 RCT (sm) 10 22.5 (19-31) 10 10 PRF None









RCT (sm) 5 22.9 (19-32) 5 5 PRP None 16












Eshgpour et al, 201435 RCT (sm) 78 25 (18-35) 78 78 PRF None 1
Mozzati et al, 201436 RCT (sm) 34 62.7 (NR) 34 34 PRGF None 3
Mozzati et al, 201437 CCT (sm) 20 63 (NR) 57 57 PRGF None 30 days
Suttapreyasri and
Leepong, 201338
RCT (sm) 8 22.6 (20-27) 10 10 PRF None 8
Antonello et al, 201339 CCT (sm) 25 NR (18-30) 25 25 PRP None 20
Hauser et al, 201340 RCT (pa) 23 47.4 (NR) 9 + 6 8 PRF; PRF + flap None 8
Farina et al, 201341 CCT (pa) 28 55.2 (34-74) 18 18 PRGF None 4-10
Batstone et al, 201242 RCT (sm) 22 54.5 (30-68) 22 22 PRP None 5 yr
Celio-Mariano et al, 201243 RCT (sm) 15 NR (18-22) 15 15 PRP None 24
Haraji et al, 201244 CCT (sm) 40 22.1 (18-45) 40 40 PRGF None 4 days
Singh et al, 201245 CCT (sm) 20 32 (18-50) 20 20 PRF None 12
G€urb€uzer et al, 201046 RCT (sm) 20 24.9 (NR) 20 20 PRF None 4
Mozzati et al, 201047 RCT (sm) 16 22.5 (18-35) 16 16 PRGF None 1
Arenaz-Bua et al, 201048 RCT (sm) 34 23 (18-45) 72 34 PRP None 12-24.
Gawande and
Halli, 200949
CCT (sm) 20 NR (18-30) 20 20 PRR None 24
Vivek and Sripathi
Rao, 200950
CCT (sm) 10 27 (18-45) 10 10 PRP None 16
G€urb€uzer et al, 200851 RCT (sm) 12 21.8 (NR) 12 12 PRP None 4
Sammartino et al, 200552 CCT (sm) 18 NR (21-26) 18 18 PRP None 18
Abbreviations: CCT, clinical controlled trial; FDBA,---; FU, follow-up; HA, hyaluronic acid; mb,---; NR, not reported;
pa, parallel design; PRF, platelet-rich fibrin; PRGF, plasma rich in growth factors; PRP, platelet-rich plasma; RCT, randomized clin-
ical trial; sm, split-mouth design; TCP,---. Q5
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1 360-400 20 NR
Kumar et al,
201623
PRF NA NA 1 NR NR NR
Ozgul et al, 201524 PRF NA NA 1 3,000 10 NA
Anitua et al, 201525 PRGF Trisodium
citrate
10% CaCl2 1 1,800 8 NR
Baslarli et al, 201526 PRF NA NA 1 3,000 10 NR
Dutta et al, 201527 PRP Citrate
phosphate
dextrose
CaCl2 2 2,000 + 3,000 15 + 10 NR
Kumar et al,
201528
PRF NA NA 1 3,000 10 NR
Marenzi et al,
201529
PRF NA NA 1 2,700 12 NA
Uyanık et al,
201530





NR 2 NR NR 8-10
Gawai and
Sobhana, 201532





NR 2 2,400 + 3,600 10 + 15 NR
Geurs et al, 201434 PRP NR NR NR NR NR NR
Eshgpour
et al, 201435










CaCl2 1 1,800 8 NR
Suttapreyasri and
Leepong, 201338







1 1,200 10 4-6
Hauser et al, 201340 PRF NA NA 1 2,700 12 NA
Farina et al, 201341 PRGF Trisodium
citrate
CaCl2 1 1,800 8 NR
Batstone et al,
201242





10% CaCl2 2 160 + 400g 20 + 15 5.3-5.6
Haraji et al, 201244 PRGF Trisodium
citrate
CaCl2 1 1,800 8 NR
Singh et al, 201245 PRF — — 1 3,000 10 NR
G€urb€uzer et al,
201046





CaCl2 1 1,800 8 NR
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studies.15 Themain advantages associated with the use
of APCs were better epithelialization of soft tissue,16
less pain,17 less swelling and trismus,18 faster alveolar
bone formation,18 more mature bone, and better orga-
nized trabeculae.16 In contrast, some studies sug-
gested there were no benefits in using APCs,
because no changes were found in the horizontal or
vertical dimension of the alveolar ridge19 or in
bone density.20
The objective of this updated systematic reviewwas
to evaluate relevant, well-designed studies dealing
with postextraction sockets preserved with APCs
and their effect on alveolar bone preservation, soft tis-
sue healing, and a patient’s quality of life.
Materials and Methods
SEARCH STRATEGY
This review was written and conducted according
to Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) guidelines.21
The focus question was, ‘‘Does the adjunct of APCs
produce benefits to postextraction socket healing for
hard and soft tissue parameters, postoperative compli-
cations, and patient’s postoperative quality of life?’’
The electronic search was performed using Med-
line, Embase, Scopus, and the Cochrane Central Regis-
ter of Controlled Trials (CENTRAL). The following












































1 1,200 15 NR
Abbreviations: CaCl2, calcium chloride; CPDA,---; NA,---; NR, not reported; PC, platelet concentrate; PRF, platelet-
rich fibrin; PRGF, plasma rich in growth factors; PRGFmod, modified plasma rich in growth factors; PRP, platelet-rich plasma. Q6















FIGURE 2. Risk-of-bias summary of included studies.
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Table 3. TOOTH TYPE, OUTCOMES, AND EVALUATION ASSESSMENT OF INCLUDED STUDIES Q7
Study Tooth Type Evaluation Assessment Outcomes APC Effects
Alissa et al, 201017 Various Clinical, Rx, health-related quality of life
questionnaire, soft tissue healing
Pain at 1-3 days; analgesic consumption at
1,2 days; bad taste, bad smell, food
stagnation, and alteration to diet; fewer
complications; soft tissue healing;
better distribution of trabecular bone
pattern
NSD for patient satisfaction
with treatment and
trabecular dimension
Ogundipe et al, 201118 Impacted 38 or 48 Pain, clinical, Rx Less pain NSD for bone density,
swelling, trismus
Girish Rao et al, 201320 38 and 48 Radio-Visio Graphic, Rx NSD in bone regeneration
Kumar et al, 201623 Impacted 38 and 48 Pain, complications, Rx Less pain NSD for quantity of bone
Ozgul et al, 201524 Impacted 38 and 48 Pain, swelling Less swelling NSD for pain





Enhanced healing of sockets and soft
tissue
Baslarli et al, 201526 Impacted 38 and 48 Osteoblast activity by scintigraphy NSD
Dutta et al, 201527 38 and 48 Soft tissue healing, dry socket, bone
regeneration, density, trabecular
formation, postoperative discomfort
Improved hard and soft tissue healing,
bone density, caused less discomfort
Kumar et al, 201528 Impacted 38 and 48 Pain, swelling, PPD, Rx, OPG Less pain, swelling, trismus, PPD NSD for bone density
Marenzi et al, 201529 Canine to molar Pain, soft tissue healing index Less pain, better healing, faster socket
closure
Uyanık et al, 201530 Impacted 38 and 48 Pain, analgesics, trismus, swelling Less pain and trismus
Cheah et al, 201431 Nonmolar teeth CBCT, histology, histomorphometry Higher mineralized bone content NSD for vertical and
horizontal aspects of ridge
Gawai and Sobhana, 201532 Impacted 38 and 48 Clinical, Rx (OPG) Greater bone density at 1 mo but not at
4 mo
Improved soft tissue healing
Durmus¸lar et al, 201433 Impacted 38 and 48 PD, PPD, clinical, Rx (OPT) Greater bone density at 3 mo but not at 1
and 6 mo
NSD for PPD
Geurs et al, 201434 Anterior, premolars Histomorphometry Increased bone graft turnover
Eshgpour et al, 201435 Impacted 38 and 48 Clinical Less alveolar osteitis
Mozzati et al, 201436 NR Residual socket volume, pain, healing
index, complications
Better healing index, smaller residual
socket volume (pain results NR)
Mozzati et al, 201437 Various Residual socket volume, pain, healing
index, complications
Better healing index, smaller residual




Premolar Clinical, Rx Sooner soft tissue healing, less horizontal
resorption
NSD for mesial and distal
resorption and bone
healing






















































































































































































































































































































































































































Hauser et al, 201340 Premolars Histomorphometry, micro-CT, clinical NSD for bone volume, trabecular




Farina et al, 201341 Various Micro-CT, histomorphometric markers No increase in bone deposition
Batstone et al, 201242 Posterior
mandibular teeth
Prevention of osteoradionecrosis, pain,
soft tissue healing
NSD for prevention of
osteoradionecrosis, pain scores, or
mucosal healing
Celio-Mariano et al, 201243 Impacted 38 and 48 Rx Faster bone formation
Haraji et al, 201244 38 and 48 Alveolar osteitis, pain, healing score Decreased alveolar osteitis, pain,
accelerated healing
Singh et al, 201245 38 and 48 Pain, soft tissue healing, Rx Better soft tissue healing, greater bone
density at 3 mo
NSD for pain
G€urb€uzer et al, 201046 Impacted 38 and 48 Scintigraphic evaluation of early
osteoblastic activity
NSD
Mozzati et al, 201047 Impacted 38 and 48 Pain, swelling Less inflammation and better healing
parameters
Arenaz-Bua et al, 201048 Impacted 38 and 48 Clinical, pain, Rx Inadequate report
Gawande and Halli, 200949 Impacted 38 and 48 Pain, swelling, Rx, OPG Less swelling, greater bone density NSD for pain
Vivek and Sripathi Rao, 200950 Impacted 38 and 48 Pain, healing index, Rx NSD for pain Better soft tissue healing,
greater density, trabecular
bone formation at 12 wk
G€urb€uzer et al, 200851 Impacted 38 and 48 Scintigraphic evaluation of early
osteoblastic activity
NSD
Sammartino et al, 200552 Impacted 38 and 48 Histology (only in APC group), clinical Decrease of PPD, improvement of CAL
Note: All outcomes were statistically significant unless otherwise specified.
Abbreviations: APC, autologous platelet concentrate; CAL, clinical attachment level; CBCT, cone-beam computed tomography; micro-CT, micro-computed tomography; NR, not
reported; NSD, no significant differences; OPG, orthopantomography; PPD, periodontal probing depth; Rx, radiography; VAS, visual analog scale.










































































































































































































































































































































































































OR platelet rich fibrin OR plasma rich in growth
factors OR platelet concentrates OR PRF OR PRP
OR PRGF) AND (postextraction socketsOR extraction
sockets OR preservation techniques OR tooth extrac-
tion OR third molar surgery). In addition, a hand
search was performed in the following dental journals:
British Dental Journal, British Journal of Oral and
Maxillofacial Surgery, Clinical Implant Dentistry
and Related Research, Clinical Oral Implants
Research, Clinical Oral Investigations, European
Journal of Oral Sciences, Implant Dentistry, Interna-
tional Journal of Oral and Maxillofacial Implants,
International Journal of Oral and Maxillofacial Sur-
gery, International Journal of Periodontics and
Restorative Dentistry, Journal of Clinical Periodon-
tology, Journal of Dental Research, Journal of
Dentistry, Journal of Maxillofacial and Oral Surgery,
Journal of Oral andMaxillofacial Surgery, Journal of
Periodontal Research, Journal of Periodontology, and
Oral Surgery, Oral Medicine, Oral Pathology, and
Oral Radiology. The reference lists of the included
studies and of the reviews also were searched for
possible additional eligible studies.
The last electronic search was performed on
February 8, 2016.
INCLUSION CRITERIA
The selection criteriawere limited to clinical studies
involving human subjects. To be included the articles
had to be controlled clinical trials or randomized clin-
ical trials, have a parallel or split-mouth design, and
have a sample size of at least 5 patients per group or
5 patients with bilateral treatment.
The studies had to use any APC in the postextraction
sockets of the experimental group. The APC could be
used alone or in conjunction with another material
(such as bone graft materials), but the only difference
between the control and experimental groups had to
be the use of APC. The studies had to provide clear
and adequate information on all agents and techniques
used for socket preservation procedures.
No restrictions on language or follow-up duration
were applied.
SELECTION OF STUDIES AND DATA COLLECTION
Titles and abstracts of the articles retrieved by the
electronic search were screened by 2 independent re-
viewers (C.B. and S.C.). Two reviewers checked
whether they met the inclusion criteria and indepen-
dently assessed the full text of studies of possible rele-
vance. Cases of disagreement were resolved by
discussion. Reasons for exclusion were recorded.
Two independent reviewers extracted the relevant
data using an Excel spreadsheet (Microsoft, Redmond,
WA). The extracted data were study design, study
setting, ethical approval, country, number of patients
and sockets in the control and experimental groups,
mean age of patients, intervention, follow-up duration,
tooth type, reason for extraction, number of dropouts,
and information on the method of APC production.
Additional extracted data on outcome variables were















FIGURE 3. Meta-analysis of studies evaluating soft tissue healing using the index of Landry at postoperative day 7. APC, autologous platelet
concentrate; CI, confidence interval; SD, standard deviation.















FIGURE 4. Meta-analysis of studies evaluating probing depth at the first postoperative month. APC, autologous platelet concentrate;
CI, confidence interval; SD, standard deviation.
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postoperative quality of life (including pain, swelling,
and other symptoms, assessed through a questionnaire
or interview), radiographic evaluation of bone healing,
clinical or radiographic evaluation of marginal bone
remodeling, and soft tissue healing.
The primary outcome measurements were:
 Any complication and adverse event (eg, alveolar
osteitis, acutely infected or inflamed alveolus)
 Postoperative discomfort and quality of life
(eg, self-reported postoperative pain on a visual
analog scale, swelling)
Secondary outcome measurements were:
 Bone healing assessed radiographically (eg, by
evaluation of bone density or trabecular bone
pattern at the extraction site) or histomorphomet-
rically (eg, assessment of percentage of bone vol-
ume)
 Clinical or radiographic evaluation of marginal
bone remodeling (eg, bone height at the vestib-
ular and lingual or palatal aspect and bone width
at the extraction region)
 Any other indirect estimation of bone regenera-
tion process (eg, through evaluation of markers
of bone metabolism, osteoblast activity)
 Clinical evaluation of soft tissue healing (eg, using
the healing index proposed by Landry or other
standard indices)
RISK OF BIAS ASSESSMENT
The methodologic quality of the selected studies
was evaluated independently by 2 reviewers (C.B.
and M.D.F.), according to the following methodologic
parameters.
Randomized Studies
 Random sequence generation method and
allocation concealment
All Studies
 Calibration and blinding of outcome assessment
 Comparability of control and treatment groups
at entry
 Clear definition of inclusion and exclusion
criteria
 Clear definition of outcomes assessment and
success criteria
 Completeness of the outcome data reported
and explanation for dropouts or withdrawal
(when applicable)
 Recall rate (it was assumed adequate if the















FIGURE 5. Meta-analysis of studies evaluating probing depth at this third postoperative month. APC, autologous platelet concentrate;
CI, confidence interval; SD, standard deviation.















FIGURE 6. Meta-analysis of studies evaluating incidence of alveolar osteitis. APC, autologous platelet concentrate; CI, confidence interval.
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 Sample size (it was considered adequate if$20
patients per group were treated)
 Number of surgeons involved (it was consid-
ered adequate if the same surgeon performed
all operations)
For missing or unclear data, the investigators were
contacted to provide additional data or clarification.
All criteria were assessed as adequate, unclear, or
inadequate except for the last 3 thatwere simply judged
as adequate or inadequate. Criteria for assessing the risk
ofbias of randomizedclinical trials in thepresent review
were adapted fromguidelines reported in theCochrane
Handbook for Systematic Reviews of Interventions
Version 5.1.0.22 Cases of disagreement were resolved
by discussion. To summarize the validity of the studies,
theywere considered to have a low risk of bias if at least
two thirds of the parameters were judged as adequate,
and they were considered to have a high risk if less
than two thirds of the parameters judged as adequate
were considered to have a high risk of bias.
DATA ANALYSIS
The data from different studies were combined by
meta-analysis only in the presence of studies with
similar comparisons reporting the same outcome mea-
surements at comparable observation times after tooth
extraction. For each trial, for dichotomous outcomes
(such as postoperative alveolar osteitis, recorded as
yes or no), the estimation of the effect of an interven-
tion was expressed as risk ratios (RRs) with 95% confi-
dence intervals (CIs). For continuous outcomes (such
as percentage of newly formed bone, alveolar bone
height, and width changes), mean differences with
95% CIs were used to synthesize data for each treat-
ment group. The statistical analysis unit, if possible,
was the patient, unless all compared studies expressed
the results as a function of the tooth. If a meta-analysis
was not feasible for a given outcome, then a qualitative
report of the results was provided.
RRs for dichotomous data and mean differences for
continuous data were combined using random-effects
models if at least 4 studies could be included in the
meta-analysis, whereas a fixed-effects model was adop-
ted if there were fewer than 4 studies. ReviewManager
5.3 (The Nordic Cochrane Center, The Cochrane
Collaboration, Copenhagen, Denmark) was used for
meta-analysis calculations and graphs. Data from
split-mouth and parallel group studieswere combined.
In addition, sensitivity analysis was performed to eval-















FIGURE 7. Meta-analysis of studies evaluating acute inflammation or infection of the alveolus. APC, autologous platelet concentrate;
CI, confidence interval.















FIGURE8. Meta-analysis of studies evaluating histomorphometric characteristics of the percentage of new bone formation at 12 postoperative
weeks. APC, autologous platelet concentrate; CI, confidence interval; SD, standard deviation.
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design (split mouth vs parallel design trial) on the over-
all estimates of effect.
Results
The selection process is presented in Figure 1. The
electronic search retrieved 399 articles and 3 more ar-
ticleswere found by hand searching. After exclusion of
duplicates, unrelated articles, and articles excluded for
a specific reason, 33 studies met the inclusion criteria
and were analyzed in this review.17,18,20,23-52
Table 1 presents the main characteristics and out-
comes of the included articles. Nine articles had a par-
allel design and 24 had a split-mouth design. Overall,
1,193 teeth were extracted from 911 patients. Six hun-
dred twenty postextraction sockets were treated with
APCs (PRP, PRF, or PRGF) and 573 sockets served as
controls (Table 1). Control sockets were left unfilled
except in 3 articles in which control sockets were
filled with bone graft materials (Table 1).
Table 2 presents the methodology for obtaining the
APC. PRP was the APC used most frequently, followed
by PRF and PRGF. All studies using PRGF adopted sys-
tematically the sameprocedure and used the same addi-
tives (anticoagulant and activator).25,36,37,41,44,47 Only
Antonello et al39 declared that they used a modified
PRGF procedure, introducing changes in many steps
of the preparation technique. Conversely, protocols
to obtain PRF and especially PRP varied considerably
for additives, centrifugation time, and speed (Table 2).
RISK-OF-BIAS ASSESSMENT
The risk-of-bias summary is presented in Figure 2.
Thirteen studies were classified as having a high risk
of bias and 20 were classified as having a low risk
of bias.
STUDIES OUTCOMES
Table 3 presents the qualitative summary of out-
comes of all included studies. A decrease in pain levels,
swelling, and patient discomfort was frequently
described by the included studies, as were improved




Index of landry. Five studies measured soft tissue
healing of the postextraction alveolus at the seventh
postoperative day17,25,27,45,50; however, only 3
reported the standard deviation, which made the
meta-analysis possible.17,25,27 The meta-analysis indi-
cated that soft tissue healing was statistically better
for sockets treated with APCs at the seventh postoper-
ative day (mean difference, 1.01; 95% CI, 0.77-1.24;
P < .05; Fig 3).
Probing depth. The probing depth in the distal
aspect of the second mandibular molar was measured
at months 1 and 3 in 2 and 3 studies, respec-
tively.28,33,52 Probing depth was minor in the APC
group at 2 periods in all studies. Meta-analysis indi-
cated that this outcome was similar for the 2 groups
in the first month (mean difference, 0.18; 95% CI,
0.66 to 0.3; P > .05) and statistically better for the
APC group at the third postoperative month (mean
















FIGURE 9. Meta-analysis of studies evaluating scintigraphic bone metabolism at 4 postoperative weeks. APC, autologous platelet concen-
trate; CI, confidence interval; SD, standard deviation.















FIGURE 10. Meta-analysis of studies evaluating bone density at the first postoperative month. APC, autologous platelet concentrate;
CI, confidence interval; SD, standard deviation.
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Patient’s Quality of Life
Alveolar osteitis. The postextraction complication
of alveolar osteitis was assessed in 10 studies, but
only 4 described the event.17,35,40,44 Despite the
frequency of the event, it was major in the control
group (8 events in APC group [1.3%] and 33 events
in control group [5.8%]), although the meta-analysis
indicated there were no statistical differences be-
tween the APC and control groups (RR = 0.20; 95%
CI, 0.03-1.18; P > .05; Fig 6).
Acute Inflammation or Infection of Alveolus.
Eleven studies assessed the presence of acute inflam-
mation or infection of the postextraction socket;
however, only 4 described the event.17,23,26,46
Although the event was major in the control group
(0 event in APC group and 5 events in control
group [0.9%]), the meta-analysis indicated there
were no statistical differences (RR = 0.27; 95% CI,
0.06-1.27; P < .05; Fig 7).
Pain. Most studies measured pain through a visual
analog scale of 10 points. Seven studies reported statis-
tical differences in pain decrease for the APC
group,17,18,23,28-30,44 and 5 studies described no
statistical differences.24,42,45,49,50 Because of the
heterogeneity of the studies and the lack of standard
deviation reported by the studies, it was not possible
to perform a meta-analysis for this outcome.
Hard Tissue Healing
Percentage of new bone. Two studies measured the
percentage of new bone at the twelfth postoperative
week through histomorphometric analysis.25,31 New
bone was statistically greater for the APC group in
1 study25 and similar in the other.31 Meta-analysis
indicated that the percentage of new bone formation
was similar for the 2 groups (mean difference,
1.55%; 95% CI, 6.37 to 9.48; P > .05; Fig 8).
Indirect measurement of bone metabolism. Two
studies measured bone metabolism by bone scintig-
raphy at the fourth postoperative week.46,51 The
meta-analysis showed that bone metabolism was
similar for the APC and control groups, even when us-
ing 2 different APCs (mean difference, 0.20; 95% CI,
0.14 to 0.54; P > .05; Fig 9).
Bone density. Bone density was measured on bidi-
mensional radiographs at the first, third, and sixth
postoperative months in 2 studies.43,49 Bone
density was statistically better for the APC group
for all 3 periods (mean difference, 5.06; 95% CI,
1.45-8.66; P < .05; mean difference, 6.66; 95% CI,
3.11-10.21; P < .05; mean difference, 7.29; 95%
CI, 4.31-10.28; P < .05; Figs 10-12).
Discussion
Tooth extraction induces several changes in the oral
physiology. The main immediate effect is a decrease in
the patient’s quality of life in the postsurgical period
because of pain, swelling, or inflammation and some-
times alveolar infection. However, the most chal-
lenging and lasting negative effects are probably
caused by alveolar bone resorption, which decreases
the size of the alveolar ridges in the vertical and,
mainly, horizontal dimensions.53 According to a recent
review, the resorption process, triggered after tooth
extraction, can cause a decrease on average of
3.79 mm in the horizontal dimension and a decrease















FIGURE 11. Meta-analysis of studies evaluating bone density at the third postoperative month. CI, confidence interval; SD, standard
deviation.















FIGURE 12. Meta-analysis of studies evaluating bone density at the sixth postoperative month. APC, autologous platelet concentrate;
CI, confidence interval; SD, standard deviation.
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extraction.53 Moreover, it is expected to last for the pa-
tient’s entire lifetime.3
Immediate and gradual effects decrease patient
satisfaction with the treatment and make subsequent
rehabilitation treatments difficult. Previous evidence
has suggested that alveolar preservation techniques,
applied soon after tooth extraction, considerably
decrease bone resorption and improve the patient’s
quality of life.25 In this scenario, the use of APCs as a
preservation technique for postextraction sockets
represents a valuable, safe, and cost-effective option.
APCs are heme components (actual blood-derived
products) obtained by centrifugation of the patient’s
own blood. What is common to all APCs is the pres-
ence of an above-baseline concentration of platelets
and, hence, an increased number of growth factors
available at the surgical area.54 The growth factors
are endogenous soluble mediators capable of modi-
fying the cellular response to a given stimulus. They
act as intercellular signals that modulate cell function
by binding to specific receptors on the cell surface
of target cells. Thus, APCs promote chemotaxis, angio-
genesis, proliferation, differentiation, and modulation
of cells involved in the healing process.
Some APCs (PRP and PRGF) can be produced with
the use of an anticoagulant and an activator and others
(PRF) can be producedwithout the use of any additive.
Thus, PRF is a complete autologous preparation.
These APCs differ not only in the method for prepara-
tion but also in their biological properties.
PRP and PRGF concentrates have a relatively short
duration of action because the activator induces a
fast release of the granule content. Thrombin activa-
tion causes 81% of total growth factors to be released
within the first day, with considerably decreased
release at 3, 7, and 14 days.55 This causes a massive,
fast, and short-term effect that makes the incorpora-
tion of cytokines difficult. In contrast, PRF does not
need an activator to produce fibrinogen polymeriza-
tion, because this occurs naturally during centrifuga-
tion. A progressive or relatively slow polymerization
mode can increase the incorporation of circulating cy-
tokines in the fibrin matrix.56 PRP releases the largest
amounts of growth factors (transforming growth
factor-1 [TGF-1] and platelet-derived growth factor
[PDGF])Q2 on the first day, followed by considerably
decreased release at later time points. PRF releases
the largest amount of TGF-1 at day 14 and the largest
amount of PDGF at day 7.56 It would be interesting
to evaluate whether there are differences among the
different types of concentrates for the clinical out-
comes; however, this was not the objective of this
study; therefore, it is not possible to recommend any
specific APC preparation. In this review, 14 included
studies used PRP, 13 used PRF, and 7 used PRGF or
modified PRGF (Table 2). Most of the variation in
outcomes among studies could be related to the use
of different products that have different compositions,
features, and likely different biological activities.
The objective of this systematic review was to eval-
uate the effect of APCs on a patient’s quality of life and
on soft and hard tissue healing after tooth extraction.
The performed meta-analysis showed benefits of
APCs for hard and soft tissue healing; bone density
measured by bidimensional radiographs at 1, 3, and
6 months, index of Landry at 7 days, and probing
depth at 3 months were improved. However, indirect
measurement of bone metabolism, percentage of new
bone, postoperative complications, and probing
depth at 1 month were similar between the APC and
control groups. Qualitative analysis of the outcomes
reported by the included studies in general was posi-
tive for the APC group (Table 3). Decreased swelling
was found in 4 of 5 studies and decreased trismus
was found in 2 of 3 studies (Table 3).
The heterogeneity among studies and the lack of re-
ported standard deviations in several studies made it
impossible to perform a meta-analysis for some out-
comes. For example, a marked decrease in pain for
the APC groupwas found in 7 studies and no statistical
differences for this outcome were found in 5 studies
(Table 3). However, as previously described, some
studies reported medians17 and others reported
means,18,25 and some studies reported pain daily24
and others reported the mean of several days.29,30
Moreover, of the comparable studies, only 1
provided the standard deviation,25 which is an essen-
tial element to perform a meta-analysis. Therefore, it
was not possible to perform a formal meta-analysis
for this outcome, as stated in previous systematic re-
views.15,57 Thus, the actual effect of APCs on
decreasing pain in extraction sockets is still not
quantifiable. In the same way, bone density was
measured using different techniques such as cone-
beam computed tomograms,25 bidimensional radio-
graphs,17 and micro-computed tomographic
methods,40 preventing a direct comparison. Neverthe-
less, it was possible to observe a substantial contribu-
tion of APCs to other aspects of a patient’s quality of
life and, mainly, to soft tissue healing after tooth extrac-
tion, which most investigators found to be enhanced.
Another common impediment for performing a
meta-analysis was the heterogeneity in the follow-up
duration or the postsurgical timing of when the out-
comeswere assessed. All these factors should be taken
into consideration for future clinical studies when re-
porting outcomes on this subject.
Althoughnot evaluated by the clinical studies consid-
ered, another important property of APC is its antimi-
crobial activity, which has been highlighted by a
recent review focusedonpreclinical studies.58 Thepos-
sibility of controlling postoperative infections is an
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important feature that could explain in part the lower
incidence of complications such as alveolar osteitis
and that makes APCs a clinically useful adjunctive tool.
The use of APCs can be advantageous for some rele-
vant clinical and radiographic outcomes after a dental
extraction procedure, such as increased bone density
and soft tissue healing according to the performed
meta-analysis and a decrease in swelling and trismus
according to the qualitative analysis. The results of
this systematic review showed that APCs should be
used in postextraction sites to improve these clinical
outcomes. The actual effect of APCs on decreasing
pain in extraction sockets is still not quantifiable.Q3
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